0001628808-17-000003.txt : 20171005 0001628808-17-000003.hdr.sgml : 20171005 20171005112144 ACCESSION NUMBER: 0001628808-17-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171005 DATE AS OF CHANGE: 20171005 EFFECTIVENESS DATE: 20171005 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Profound Medical Corp. CENTRAL INDEX KEY: 0001628808 IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-296067 FILM NUMBER: 171123640 BUSINESS ADDRESS: STREET 1: 2400 SKYMARK AVENUE, UNIT 6 CITY: MISSISSAUGA STATE: A6 ZIP: L4W 5K5 BUSINESS PHONE: 647-476-1350 MAIL ADDRESS: STREET 1: 2400 SKYMARK AVENUE, UNIT 6 CITY: MISSISSAUGA STATE: A6 ZIP: L4W 5K5 FORMER COMPANY: FORMER CONFORMED NAME: Profound Medical Inc. DATE OF NAME CHANGE: 20141222 D 1 primary_doc.xml X0708 D LIVE 0001628808 Profound Medical Corp. 2400 SKYMARK AVENUE, UNIT 6 MISSISSAUGA A6 ONTARIO, CANADA L4W 5K5 647-476-1350 ONTARIO, CANADA Profound Medical Inc. Corporation true 2014 Damian Lamb 2400 Skymark Avenue, Unit 6 Mississauga A6 ONTARIO, CANADA L4W 5K5 Director Jean-Francois Pariseau 2400 Skymark Avenue, Unit 6 Mississauga A6 ONTARIO, CANADA L4W 5K5 Director William Curran 2400 Skymark Avenue, Unit 6 Mississauga A6 ONTARIO, CANADA L4W 5K5 Director Arun Menawat 2400 Skymark Avenue, Unit 6 Mississauga A6 ONTARIO, CANADA L4W 5K5 Executive Officer Director Kenneth Galbraith 2400 Skymark Avenue, Unit 6 Mississauga A6 ONTARIO, CANADA L4W 5K5 Director Samira Sakhia 2400 Skymark Avenue, Unit 6 Mississauga A6 ONTARIO, CANADA L4W 5K5 Director Rashed Dewan 2400 Skymark Avenue, Unit 6 Mississauga A6 ONTARIO, CANADA L4W 5K5 Executive Officer Biotechnology No Revenues 06b false 2017-09-20 false true Units (common shares and warrants to purchase common shares) false 0 CIBC World Markets Inc. 16190 CIBC World Markets Corp. 630 425 Lexington Avenue New York NY NEW YORK 10017 IL ILLINOIS MD MARYLAND NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA false 877471 877471 0 This assumes Canadian/U.S. exchange rate of $1/1.2536. It does not reflect over-allotment option, which is exercisable until October 20, 2017. false 16 52648 0 Underwriting fees paid by the issuer in respect of U.S. subscribers 0 false Profound Medical Corp. /s/ Rashed Dewan Rashed Dewan Vice President, Finance 2017-10-05